Mohammed; Abdul Rasheed

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mohammed; Abdul Rasheed.The latest application filed is for "new uses of a 5-ht4 receptor agonist".

Company Profile

9.19.18

Mohammed; Abdul Rasheed - Hyderabad IN
Mohammed; Abdul Rasheed - Telangana IN
Mohammed; Abdul Rasheed - Banjara Hills Hyderabad
Mohammed; Abdul Rasheed - Andhra Pradesh IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polycyclic amides as muscarinic M1 receptor positive allosteric modulators Grant 11,278,530 - Nirogi , et al. March 22, 2	2022-03-22
Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulators Grant 11,234,979 - Nirogi , et al. February 1, 2	2022-02-01
New Uses Of A 5-ht4 Receptor Agonist App 20210386727 - NIROGI; Ramakrishna ; et al.	2021-12-16
Substituted Azacycles As Muscarinic M1 Receptor Positive Allosteric Modulators App 20210369685 - NIROGI; Ramakrishna ; et al.	2021-12-02
Muscarinic M1 receptor positive allosteric modulators Grant 11,040,026 - Nirogi , et al. June 22, 2	2021-06-22
Fluoropiperidine compounds as pure 5-HT 6 receptor antagonists Grant 10,973,831 - Nirogi , et al. April 13, 2	2021-04-13
Polycyclic Amides As Muscarinic M1 Receptor Positive Allosteric Modulators App 20200297703 - NIROGI; Ramakrishna ; et al.	2020-09-24
Fluoropiperidine Compounds As Pure 5-ht 6 Receptor Antagonists App 20200155560 - NIROGI; Ramakrishna ; et al.	2020-05-21
Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors Grant 10,603,323 - Nirogi , et al.	2020-03-31
Muscarinic M1 Receptor Positive Allosteric Modulators App 20190343812 - NIROGI; Ramakrishna ; et al.	2019-11-14
Triple Combination Of Histamine-3 Receptor Inverse Agonists, Acetylcholinesterase Inhibitors And Nmda Receptor Antagonist App 20190336509 - NIROGI; Ramakrishna ; et al.	2019-11-07
Muscarinic M1 receptor positive allosteric modulators Grant 10,308,620 - Nirogi , et al.	2019-06-04
Combination Of Histamine-3 Receptor Inverse Agonists With Acetylcholinesterase Inhibitors App 20190160075 - NIROGI; Ramakrishna ; et al.	2019-05-30
Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulators Grant 10,294,217 - Nirogi , et al.	2019-05-21
Fluoroindole Derivatives as Muscarinic M1 Receptor Positive Allosteric Modulators App 20180244655 - Nirogi; Ramakrishna ; et al.	2018-08-30
Process for large scale production of 1-isopropyl-3-{5-[1-(3-methoxypropyl)piperidin-4-YL]-[1,3,4]oxadiazol-2-Y- L}-1H-indazole oxalate Grant 10,005,711 - Nirogi , et al. June 26, 2	2018-06-26
Muscarinic M1 Receptor Positive Allosteric Modulators App 20180155302 - Nirogi; Ramakrishna ; et al.	2018-06-07
Amide compounds as 5-HT4 receptor agonists Grant 9,957,257 - Nirogi , et al. May 1, 2	2018-05-01
Indazole compounds as 5-HT.sub.4 receptor agonists Grant 9,951,045 - Nirogi , et al. April 24, 2	2018-04-24
Amide Compounds As 5-ht4 Receptor Agonists App 20180051011 - NIROGI; Ramakrishna ; et al.	2018-02-22
Process For Large Scale Production Of 1-isopropyl-3--1h-indazole Oxalate App 20170283359 - NIROGI; Ramakrishna ; et al.	2017-10-05
Heteroaryl compounds as 5-HT.sub.4 receptor ligands Grant 9,636,335 - Nirogi , et al. May 2, 2	2017-05-02
Indazole Compounds As 5-ht4 Receptor Agonists App 20160311797 - NIROGI; Ramakrishna ; et al.	2016-10-27
Heteroaryl Compounds As 5-ht4 Receptor Ligands App 20150283125 - NIROGI; Ramakrishna ; et al.	2015-10-08
Heteroaryl compounds as 5-HT.sub.4 receptor ligands Grant 9,079,894 - Nirogi , et al. July 14, 2	2015-07-14
Heteroaryl Compounds As 5-ht4 Receptor Ligands App 20140187581 - Nirogi; Ramakrishna ; et al.	2014-07-03
Bicyclic compounds as .alpha..sub.4.beta..sub.2 nicotinic acetylcholine receptor ligands Grant 8,735,423 - Nirogi , et al. May 27, 2	2014-05-27
.alpha..sub.4.beta..sub.2 neuronal nicotinic acetylcholine receptor ligands Grant 8,653,071 - Nirogi , et al. February 18, 2	2014-02-18
1,2-dihydro-2-oxoquinoline compounds as 5-HT.sub.4 receptor ligands Grant 8,598,204 - Nirogi , et al. December 3, 2	2013-12-03
BICYCLIC COMPOUNDS AS alpha4 beta2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS App 20130072518 - Nirogi; Ramakrishna ; et al.	2013-03-21
Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS App 20120322808 - Nirogi; Ramakrishna ; et al.	2012-12-20
1,2-dihydro-2-oxoquinoline Compounds As 5-ht4 Receptor Ligands App 20120277216 - Nirogi; Ramakrishna ; et al.	2012-11-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.